Gross G N
Department of Internal Medicine, University of Texas Southwestern Medical School, Dallas.
Tex Med. 1992 Aug;88(8):58-62.
The treatment of patients with asthma in this decade requires an understanding of the inflammatory process in their airways. A combination of bronchodilators and inhaled medications that reduce or prevent this inflammatory process provides the best treatment for this population. Because the inhaled anti-inflammatory medications do not offer the immediate clinical response that bronchodilators will provide, patient education regarding proper management becomes more critical. The patient's assistance in frequently monitoring the function of the airway can help both the patient and the physician implement the necessary changes in medications to reduce the severity of or to prevent an asthma attack. Through these monitoring and treatment techniques, mortality and morbidity caused by asthma can be reduced.
在这十年中，哮喘患者的治疗需要了解其气道中的炎症过程。支气管扩张剂和吸入药物的组合可减少或预防这种炎症过程，为这一人群提供了最佳治疗方案。由于吸入性抗炎药物不能像支气管扩张剂那样提供即时的临床反应，因此关于正确管理的患者教育变得更加关键。患者在频繁监测气道功能方面的协助，有助于患者和医生对药物进行必要的调整，以减轻哮喘发作的严重程度或预防哮喘发作。通过这些监测和治疗技术，可以降低哮喘导致的死亡率和发病率。
